demonstrated that the suppression of Mettl3 in NK cells results in diminished m6A levels and SHP-2 activity, consequently impairing the anti-tumor response of NK cells by reducing their sensitivity to IL-15 (23). This evidence concerns the gene METTL3 and neoplasm.